Elanco

During the Transition Excellence Symposium and the 33rd World Buiatrics Congress, colleagues, veterinarians, researchers and industry experts came together with one shared focus: advancing ruminant health. Under the theme "From Dry-Off to Peak Performance," leading international experts shared the latest scientific insights and practical approaches related to the Vital 90 Days of dairy health. Topics ranged from successful dry-off and transition-cow management to immune activation, fresh-cow preparation, stress mitigation and innovative pheromone technology. Beyond the scientific program, the event provided a valuable opportunity to exchange experiences, strengthen international relationships and create new connections across the global ruminant-health community. A sincere thank you to our speakers, guests, colleagues and partners for contributing their expertise, energy and enthusiasm. Together, we are turning science into practical solutions that support healthier animals and more sustainable livestock production.

Aumento della mortalità. Riduzione dell'incremento ponderale. Peggioramento dell'FCR. L'enterite continua a rappresentare una sfida complessa e costosa per i produttori avicoli di tutto il mondo. Il nostro Global Enteritis Monitoring Assessment (GEMA) integra le prospettive e le analisi di veterinari, nutrizionisti e produttori per delineare la reale entità del problema a livello globale. Sfoglia il carosello per scoprire cosa rivelano i dati e quali sono le implicazioni per la salute dei tuoi gruppi. #Avicoltura #Enterite #Coccidiosi #PoultryProduction #FCR #SaluteAnimale #GEMA

New third-party data backs up something we hear from pet owners every day: companion animal health isn't a "nice to have," it's a protected budget item. A new Harris Poll survey (conducted for the AICPA) found that 69% of US pet owners would cut their own spending before reducing spending on their pets — a number that jumps to 81% among owners 65+. Companion animal health and wellness remain an absolute priority for pet owners, even as household budgets tighten elsewhere.

We brought the best of Elanco to our favorite people for Family Day at our Indianapolis HQ! It was a day centered on what matters most: connection. From pickleball games to meeting new furry friends, the energy was unmatched. We're proud to celebrate our Healthy Purpose alongside the people who support us every day.

Today we announced the on-time completion of a 25,000-square-foot expansion at our Elwood, Kansas site as part of a broader $150 million total investment through 2028 – strengthening Elanco's leadership in the biologics space as one of only two animal health companies with mAb solutions on the market today. This facility is more than an infrastructure update; it supports the delivery of our next generation portfolio. As pet owners' expectations for care reach new heights, the demand for innovation increases. This prioritization reflects a growing demand for comprehensive portfolios and innovative solutions, such as monoclonal antibodies, that can enhance the quality of life for pets. Learn more about how we are scaling our global manufacturing capabilities: https://bit.ly/4zElU0C

For food companies, Scope 3 ambition is only as valuable as your ability to turn it into credible, measurable action across the supply chain. At Elanco, we’re helping food companies do exactly that—combining animal health innovation, on-farm expertise, advanced analytics and carbon accounting capabilities to turn sustainability goals into credible outcomes from farm to food company. Meredith Varie recently shared our approach and latest capabilities at the Carbon Accounting in Agricultural Supply Chains Summit in Chicago, joining food and agriculture leaders to tackle a critical question: How do we operationalize evolving carbon accounting standards across beef and dairy supply chains—and translate them into meaningful Scope 3 progress? Our perspective is clear: 🔹Start with the claim. Programs should be designed around the outcomes partners need to credibly measure and report. 🔹Keep farmers at the center. Lasting progress depends on programs that work on the farm, support producer livelihoods and create a positive experience. 🔹Build for rigor and scale. Strong data, verification and implementation capabilities are essential to moving from sustainability ambition to measurable impact. What makes Elanco different? 🔹People. Experienced sustainability and animal agriculture experts with the field presence to support programs from farm identification through implementation and verification. 🔹Programs. Four distinct supply-chain emissions reduction and intensity programs—now independently validated and verified—designed to deliver high-quality outcomes while adapting to partners’ specific claiming needs. 🔹Primary data. UpLook™ and Benchmark provide robust farm-level data collection, quantification and insights, supported by IPCC-aligned methodologies and the latest scientific research. For CPG and food companies looking to make credible progress against Scope 3 targets, the opportunity isn’t simply to measure emissions—it’s to build programs that can reduce them. We’re partnering across the beef and dairy value chains to create end-to-end solutions that connect farm-level action with transparent, credible and claimable outcomes. Interested in what this could look like in your supply chain? Let’s talk. #CarbonAccounting #Scope3 #SustainabilityReporting #AgRetail #CPG #GHGP #Decarbonization

The Riverside Department of Animal Services recently reached a milestone that represents a paradigm shift in shelter medicine. By implementing Trutect™ (formerly Canine Parvovirus Monoclonal Antibody)—the first and only USDA-approved treatment for Canine Parvovirus—they have successfully achieved a 63% reduction in Parvo-related euthanasia rates year-to-date. This dramatic shift is the direct result of what happens when visionary leadership meets first-of-its-kind innovation. For decades, Parvo was a devastating diagnosis for shelters; today, Trutect™ provides the tool veterinarians need to fight back and win. At Elanco, this progress is the living embodiment of our mission: making life better for animals, makes life better. By providing the science to turn a diagnosis of parvovirus into a story of recovery, we are not just advancing veterinary medicine—we are strengthening the essential bond between pets and the communities that care for them.

The re-emergence of New World screwworm (NWS) in the United States represents a significant shift in the parasitic landscape. By collaborating closely with the FDA, EPA and USDA, Elanco has secured more Emergency Use Authorizations and conditional approvals for NWS than any other animal health company. Credelio Quattro™-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) is the first and only FDA-conditionally approved treatment for NWS larvae infestations in dogs and puppies 8 weeks of age and older and weighing 3.3 pounds or greater. This milestone demonstrates our "Healthy Purpose" in action—ensuring that veterinarians and pet owners have the tools they need to be prepared. Read the full article from Dr. Casey Locklear, DVM, veterinarian and leading parasiticides expert at Elanco, on managing this emerging threat here: https://bit.ly/4ct3F4s View the full Credelio Quattro/Credelio Quattro-CA1 product label at CredelioQuattroLabel.com.

If hunger were a country, it would be the third largest in the world. Addressing a crisis of this scale requires more than incremental change. It requires massive action. In the latest episode of Shared Table, Elanco CEO Jeff Simmons and Tony Robbins discuss their fight against hunger: The Coalition to Close the Protein Gap. But this conversation goes beyond logistics; it is a masterclass in the leadership mindset required to turn “impossible” goals into reality. From the “Protein Revolution” to the philosophy of creating the future rather than managing circumstances, this Shared Table conversation explores how a personal “why” can become a global “how.” Watch the full episode here: https://lnkd.in/eCtc2HEt

With the confirmed reentry of New World screwworm into the United States, prevention is key. Elanco is committed to supporting the animal health industry. Today, we secured an Emergency Use Authorization from the U.S. Food and Drug Administration for another preventative solution. By providing livestock producers and veterinarians with the means for early intervention, we are reaffirming our dedication to protecting animal health and producers' livelihoods. Read the full press release: https://bit.ly/4wFMh4w